British American Tobacco's shares tumble; conclusions after 2024 earnings reportšŸ’”

12:38 13 February 2025

Shares of British American Tobacco (BATS.UK) are losing 7.5% in today's session, after the company's forecasts for revenue growth in fiscal 2025 did not prove good enough to sustain the sizable gains we've seen in the company's stock recently. However, this does not change the fact that the results themselves were relatively good. In F2024, the decline in operating profit in the US (-3.5%) was more than offset by growth in other countries (+7.5%), allowing BAT to maintain group-level growth (+1.4%). The performance of new non-combustion alternative product categories, such as Velo, is also encouraging.Ā 

The company sees the main negative factors for the year as:

Start investing today or test a free demo

Open account Try demo Download mobile app Download mobile app
  • Bangladesh: Acceleration of illegal trade driven by VAT and customs duty increases. (BAT's largest market)
  • Australia: Acceleration of illegal trade driven by ad hoc excise tax increases

The negative impact is estimated at: ~1% on revenues, ~2% on operating profit

Below are selected results presented by the company:

ANNUAL FORECAST

  • Adjusted operating profit +1.5% to +2.5%

The most important aspects that may affect share valuation this year. Source: BAT

2024 EARNINGS

  • Adjusted operating profit Ā£11.89 billion, estimates Ā£11.96 billion
  • Operating profit Ā£2.74 billion vs. last year's loss Ā£15.75 billion y/y, estimate Ā£10.71 billion
  • Revenue Ā£25.87 billion, estimates Ā£26.31 billion
  • Dividend per share 240.24 pence, forecast 237.55 pence
  • Adjusted earnings per share 362.5 pence, forecast 362.9 pence

CONCLUSIONS:

The company's results do not fare badly, although after such a large appreciation in BATS' share price, a large part of the market might have expected the future outlook to be more optimistic. Industry media reported that a key topic during this release would be any mention of the performance of alternative products. In this aspect, the results did not spoil, indicating a nearly 6% decline in vaporizer volumes and a nearly 12% decline in heater volumes (the company's key alternative products). Thus, they offset the positive surprise of the powerful growth in sales of Velo pouches. It is worth remembering that for tobacco companies, the key element of the transformation will be precisely the increase in the share of alternative products in the revenue structure.

Share of each group in BATS revenue. Source: BAT

The company's shares tested the 50-day EMA today (blue curve on the chart), after which the demand side managed to negate part of the initial discounts.Ā 

Source: xStation


Ā 

This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.

Back

Join over 1 Million investors from around the world